Quaia Emilio, Calliada Fabrizio, Bertolotto Michele, Rossi Sandro, Garioni Lorena, Rosa Laura, Pozzi-Mucelli Roberto
Department of Radiology, Cattinara Hospital, University of Trieste, Strada di Fiume 447, Trieste 34149, Italy.
Radiology. 2004 Aug;232(2):420-30. doi: 10.1148/radiol.2322031401.
To assess whether characterization of solid focal liver lesions could be improved by using ultrasonographic (US) contrast-specific modes after sulfur hexafluoride-filled microbubble contrast agent injection, as compared with lesion characterization achieved with preliminary baseline US.
Four hundred fifty-two solid focal hepatic lesions that were considered indeterminate at baseline gray-scale and color Doppler US were examined after microbubble contrast agent injection performed by using low-acoustic-power contrast-specific modes during the arterial (10-40 seconds after injection), portal venous (50-90 seconds after injection), and late (100-300 seconds after injection) phases. Two readers independently and retrospectively reviewed baseline and contrast material-enhanced US scans and classified each depicted lesion as malignant or benign according to standard diagnostic criteria. Sensitivity, specificity, accuracy, and positive and negative predictive values and areas under the receiver operating characteristic curve (Az) were calculated by considering histologic analysis (317 patients) or contrast-enhanced helical computed tomography followed by serial US 3-6 months apart (135 patients) as the reference standards.
Different contrast enhancement patterns were observed according to lesion characteristics. During the late phase, benign lesions were predominantly hyper- or isoechoic relative to the adjacent liver parenchyma, whereas malignant lesions were predominantly hypoechoic. Review of the contrast-enhanced US scans after baseline image review yielded significantly improved diagnostic performance (P <.05). Overall diagnostic accuracy was 49% before versus 85% after review of the contrast-enhanced scan for reader 1 and 51% before versus 88% after review of the contrast-enhanced scan for reader 2. Diagnostic confidence-that is, the Az-was 0.820 before versus 0.968 after review of the contrast-enhanced scan for reader 1 and 0.831 before versus 0.978 after review of the contrast-enhanced scan for reader 2.
The use of contrast-specific modes with a sulfur hexafluoride contrast agent led to improved characterization of solid focal liver lesions.
评估与初步基线超声检查相比,注射六氟化硫填充微泡造影剂后使用超声(US)造影特异性模式是否能改善肝脏实性局灶性病变的特征描述。
对452个在基线灰阶和彩色多普勒超声检查时被认为不确定的肝脏实性局灶性病变,在注射微泡造影剂后,于动脉期(注射后10 - 40秒)、门静脉期(注射后50 - 90秒)和延迟期(注射后100 - 300秒)使用低声功率造影特异性模式进行检查。两名阅片者独立且回顾性地分析基线和造影剂增强后的超声扫描图像,并根据标准诊断标准将每个显示的病变分类为恶性或良性。以组织学分析(317例患者)或间隔3 - 6个月的对比增强螺旋CT随后连续超声检查(135例患者)作为参考标准,计算敏感性、特异性、准确性、阳性和阴性预测值以及受试者操作特征曲线下面积(Az)。
根据病变特征观察到不同的造影增强模式。在延迟期,良性病变相对于相邻肝实质主要为高回声或等回声,而恶性病变主要为低回声。在回顾基线图像后再查看造影增强超声扫描图像,诊断性能有显著改善(P <.05)。对于阅片者1,造影增强扫描回顾前总体诊断准确性为49%,回顾后为85%;对于阅片者2,造影增强扫描回顾前为51%,回顾后为88%。诊断信心(即Az),阅片者1在造影增强扫描回顾前为0.820,回顾后为0.968;阅片者2在造影增强扫描回顾前为0.831,回顾后为0.978。
使用六氟化硫造影剂的造影特异性模式可改善肝脏实性局灶性病变的特征描述。